It is not clear whether high-quality coincidence gamma-PET (gPET) cameras can provide clinical data comparable with data obtained with dedicated PET (dPET) cameras in the primary diagnostic work-up of patients with suspected lung cancer. This study focuses on 2 main issues: direct comparison between foci resolved with the 2 different PET scanners and the diagnostic accuracy compared with final diagnosis determined by the combined information from all other investigations and clinical follow-up. Methods: Eighty-six patients were recruited to this study through a routine diagnostic program. They all had changes on their chest radiographs, suggesting malignant lung tumor. In addition to the standard diagnostic program, each patient had 2 PET s...
Despite advances in morphological imaging, some patients with lung cancer are found to have nonresec...
Objectives To investigate the potential of automatic lung cancer detection on submillisievert dose F...
Guidelines issued by the National Institute for Clinical Excellence (NICE) in the England and Wales ...
The accurate detection of lung carcinoma and the determination of its stage remain significant clini...
The purpose of this study was to compare the utility of a dual-head positron coincidence detection g...
18F-FDG PET has reached widespread application in the assess-ment of pulmonary nodules. This study c...
Background: Lung cancer is one of the most common Malignancies worldwide. Hence, timely diagnosis an...
Objective: Dual-head gamma cameras with sodium iodide(NaI) detectors operated in coincidence mode pr...
PET has seen rapid progression in recent years, with appli-cations in oncology leading the way. The ...
In this study, we prospectively compared the sensitivity of PET and planar SPET (collimated gamma ca...
Background18F-fluorodeoxyglucose (FDG) PET/CT is recommended for evaluation of intermediate-risk ind...
We compared the diagnostic value of [18F]2-fluoro-2-deoxy-D-glucose (FDG) PET imaging and 201TISPECT...
18F-FDG PET is increasingly used for lung cancer; however, some insufficient results have been repor...
IMPORTANCE Positron emission tomography (PET) combined with fludeoxyglucose F 18 (FDG) is recommende...
Abstract:In the past 10 years, positron emission tomography (PET), usually with 18F-fluoro-2-deoxy-D...
Despite advances in morphological imaging, some patients with lung cancer are found to have nonresec...
Objectives To investigate the potential of automatic lung cancer detection on submillisievert dose F...
Guidelines issued by the National Institute for Clinical Excellence (NICE) in the England and Wales ...
The accurate detection of lung carcinoma and the determination of its stage remain significant clini...
The purpose of this study was to compare the utility of a dual-head positron coincidence detection g...
18F-FDG PET has reached widespread application in the assess-ment of pulmonary nodules. This study c...
Background: Lung cancer is one of the most common Malignancies worldwide. Hence, timely diagnosis an...
Objective: Dual-head gamma cameras with sodium iodide(NaI) detectors operated in coincidence mode pr...
PET has seen rapid progression in recent years, with appli-cations in oncology leading the way. The ...
In this study, we prospectively compared the sensitivity of PET and planar SPET (collimated gamma ca...
Background18F-fluorodeoxyglucose (FDG) PET/CT is recommended for evaluation of intermediate-risk ind...
We compared the diagnostic value of [18F]2-fluoro-2-deoxy-D-glucose (FDG) PET imaging and 201TISPECT...
18F-FDG PET is increasingly used for lung cancer; however, some insufficient results have been repor...
IMPORTANCE Positron emission tomography (PET) combined with fludeoxyglucose F 18 (FDG) is recommende...
Abstract:In the past 10 years, positron emission tomography (PET), usually with 18F-fluoro-2-deoxy-D...
Despite advances in morphological imaging, some patients with lung cancer are found to have nonresec...
Objectives To investigate the potential of automatic lung cancer detection on submillisievert dose F...
Guidelines issued by the National Institute for Clinical Excellence (NICE) in the England and Wales ...